CTOs on the Move

Invacare

www.invacare.com

 
Since 1885, Invacare has helped people with disabilities live life. Today, Invacare is the global leader in home and long-term-care medical products. Invacare Corporation (NYSE: IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. Invacare employs approximately 4,700 associates and markets its products in 80 countries around the world. The Company is listed on the New York Stock Exchange under the symbol IVC.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Angela Goodwin
 Chief Information Officer Profile

Similar Companies

Interbiolab

Interbiolab is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Archer OpTx Inc

Archer OpTx Inc is a Rowlett, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Park Surgical

Park Surgical is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Consulting Group

Medical Consulting Group is a Springfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GenMark Diagnostics

In 1993, a novel technology was invented by a team that included Jon Faiz Kayyem, PhD at The California Institute of Technology (CalTech). This invention combined nucleic acids and microelectronics to produce an electronic sensor for DNA detection. His invention was based on electrical detection of nucleic acids on a cassette based detection platform. Dr. Kayyem went on to found Clinical Micro Sensors, with the goal of translating this “eSensor” technology to disposable chips. Following several acquisitions of the technology, Dr. Kayyem became actively involved again in 2009, returning as an investor and then as CEO and Chairman of the Board. In 2009, a collaboration between Dr. Kayyem and Christopher Gleeson began. The two redefined the company strategy, and brought in a new board of directors, executive leadership team, and commercial management. In 2010, the company known at that time as Osmetech, was named GenMark Diagnostics and listed on NASDAQ. Mr. Gleeson remained an integral part of GenMark`s growth in the years that followed, serving as Chairman of the Board until his retirement in 2014. Dr. Kayyem currently serves as SVP, Research and Development.